SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 261.79
( 0.34%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,673.34 20.47
(0.19%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

53.0163986

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

61.52

244.22

EPS(TTM)

Face Value()

Div & Yield %

1.4

Back

vikas globalone ltd

KSB consolidated net profit declines 22.87% in the March 2026 quarter

Apr 30,2026

Net profit of KSB declined 22.87% to Rs 39.80 crore in the quarter ended March 2026 as against Rs 51.60 crore during the previous quarter ended March 2025. Sales rose 0.99% to Rs 601.30 crore in the quarter ended March 2026 as against Rs 595.40 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	601.30	595.40	1
OPM %	8.45	11.37	-
PBDT	67.80	82.90	-18
PBT	53.30	69.00	-23
NP	39.80	51.60	-23

77,763.91 261.79 ( 0.34%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,733.68 1,000.53 (1.46%)

10,673.34 20.47 (0.19%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)